Literature DB >> 18217973

Paraneoplastic cerebellar degeneration in ovarian carcinoma: case report with review of immune modulation.

W H Bradley1, P R Dottino, J Rahaman.   

Abstract

Paraneoplastic cerebellar degeneration (PCD) is a rare nonmetastatic complication of a carcinoma. It is typically mediated by antibodies generated against tumor antigens. These antigens are the same proteins as expressed on Purkinje cells within the cerebellum; immune activation in the central nervous system (CNS) results in the syndrome. A 56-year-old woman with stage IIIC serous ovarian carcinoma diagnosed 3 years prior developed progressive limb ataxia. Serum anti-Yo antibodies were positive, confirming the diagnosis of PCD. Treatment with plasmaphoresis, intravenous immune globulin, and immune modulation with corticosteroids and tacrolimus was unsuccessful. Although the syndrome can be debilitating and treatment options are limited, it may also be an example of a successful host immune response in certain cases.

Entities:  

Mesh:

Year:  2008        PMID: 18217973     DOI: 10.1111/j.1525-1438.2007.01173.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  Paraneoplastic Neurological Syndrome in Fallopian Tube Cancer.

Authors:  E Maas; T Skoberne; A Werner; S Braun; C Jackisch
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-10       Impact factor: 2.915

Review 2.  Paraneoplastic syndromes of the CNS.

Authors:  Josep Dalmau; Myrna R Rosenfeld
Journal:  Lancet Neurol       Date:  2008-04       Impact factor: 44.182

3.  Ovarian cancer revealed by paraneoplastic cerebellar degeneration: a case report.

Authors:  Fadwa Elomrani; Imane Ouziane; Saber Boutayeb; Youssef Bensouda; Hind Mrabti; Hassan Errihani
Journal:  Pan Afr Med J       Date:  2014-05-01

Review 4.  Therapeutic Plasma Exchange: For Cancer Patients.

Authors:  Yuru Hu; Hanshan Yang; Shaozhi Fu; Jingbo Wu
Journal:  Cancer Manag Res       Date:  2022-02-02       Impact factor: 3.989

5.  Anti-Yo antibody-positive paraneoplastic cerebellar degeneration in a patient with possible cholangiocarcinoma: A case report and review of the literature.

Authors:  Yue Lou; Shan-Hu Xu; Si-Ran Zhang; Qin-Fen Shu; Xiao-Li Liu
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

Review 6.  Paraneoplastic cerebellar degeneration with anti-Yo antibodies - a review.

Authors:  Anand Venkatraman; Puneet Opal
Journal:  Ann Clin Transl Neurol       Date:  2016-06-30       Impact factor: 4.511

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.